Dermagraft tissue gets FDA panel scrutiny:
This article was originally published in Clinica
Executive Summary
An FDA panel will examine a premarket approval application for Dermagraft living dermal tissue as a diabetic foot ulcer treatment on January 29. The PMA is submitted by Advanced Tissue Sciences backed by Smith & Nephew.